A Pilot Study to Evaluate if Response to Infliximab or Adalimumab May be Regained With the Addition of an Immunomodulator

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02413047

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:31.358397+00:00

Published At

2019-11-04T00:00:00+00:00

Record Updated At

2019-11-04

Results Posted At

2019-11-04

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Inflammatory Bowel Disease", "Ulcerative Colitis", "Crohn\u0027s Disease"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2019-11-04"

protocolSection.identificationModule.nctId

"NCT02413047"

protocolSection.identificationModule.officialTitle

"A Pilot Study to Evaluate if Response to Infliximab or Adalimumab May be Regained With the Addition of an Immunomodulator"

protocolSection.statusModule.overallStatus

"TERMINATED"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2019-11-04"

Study condition terms

• Inflammatory Bowel Disease (protocolSection.conditionsModule.conditions)
• Ulcerative Colitis (protocolSection.conditionsModule.conditions)
• Crohn's Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.